APGEvs its industry peers
A metric-by-metric comparison of APGE against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APGEThis | $10.0B#5 | — | — | — | — | -40.5%#4 | — | — | — | — | — | — |
| INSM | $21.7B#2 | — | 30.7x#3 | 35.7x#4 | 66.7%#3 | -39.7%#3 | -205.6%#4 | -181.1%#3 | -185.1%#1 | 4#1 | — | — |
| UTHR | $22.2B#1 | 19.3x#1 | 3.8x#1 | 7.0x#1 | 10.6%#4 | 11.7%#2 | 46.9%#1 | 22.6%#1 | — | — | — | — |
| ARWR | $12.0B#4 | — | 19.6x#2 | 14.5x#2 | 23258.2%#1 | 99.7%#1 | 11.9%#2 | -0.3%#2 | — | — | — | — |
| BBIO | $15.9B#3 | — | — | 31.6x#3 | 126.3%#2 | — | -104.2%#3 | — | — | — | — | 0.0%#1 |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-07-31.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice